ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
3 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
31
|
8.8K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
39 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
87
|
18K
|
39
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
7 |
05/05/24 |
05/05/24 |
ASX - By Stock
|
31
|
8.8K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
6 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
87
|
18K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
14 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
87
|
18K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
16 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
87
|
18K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
43 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
87
|
18K
|
43
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
17 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
23 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Corporate action
|
|
adreamer
|
87 |
18K |
19 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
87
|
18K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
adreamer
|
104 |
17K |
15 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
17K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
adreamer
|
104 |
17K |
5 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
104
|
17K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
7 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
adreamer
|
104 |
17K |
14 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
104
|
17K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
adreamer
|
104 |
17K |
17 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
104
|
17K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
5 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
6 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
6 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
8 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
261
|
64K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
9 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
15 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
1.3K
|
327K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
10 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
25 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
261
|
64K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
11 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
31
|
8.8K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
8 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
31
|
8.8K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
14 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
31
|
8.8K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
12 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
23 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
261
|
64K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
6 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
64K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
13 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
261
|
64K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
10 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
31
|
8.8K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
20 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
25 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
261
|
64K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
15 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
9 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
28 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
adreamer
|
261 |
64K |
18 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
261
|
64K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
10 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
31
|
8.8K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
4 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
31
|
8.8K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
adreamer
|
1.3K |
327K |
16 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.3K
|
327K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
adreamer
|
37 |
8.8K |
10 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
adreamer
|
37 |
8.8K |
21 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
adreamer
|
37 |
8.8K |
21 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
21
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
adreamer
|
37 |
8.8K |
25 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.8K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Walk to Defeat MND
|
|
adreamer
|
31 |
8.8K |
9 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
31
|
8.8K
|
9
|
|